Speckman i can see those orders at 25 s as a blocker and institutions accumulating below that line before our next ann.I maybe wrong though..... Cheers Kevin.....
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
